Trial Profile
1-Year Longitudinal Follow-up Study of Serologic Responses to 7-Valent Pneumococcal Conjugated Vaccination and Opsonophagocytic Activities for Streptococcus Pneumoniae Among Patients With Human Immunodeficiency Virus Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 28 Apr 2015 Results of 5 years follow up presented at the 25th European Congress of Clinical Microbiology and Infectious Diseases .
- 23 Apr 2009 New trial record